Cargando…
血液肿瘤患者回输嵌合抗原受体T细胞后28天内感染病原学和临床特征分析
OBJECTIVE: To explore the incidence, clinical and microbiological characteristics and risk factors of infection in patients with acute lymphoblastic (ALL), non-Hodgkin lymphoma (NHL), and multiple myeloma (MM) within 28 days after CAR-T cell infusion. It provides data support for early identificatio...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607031/ https://www.ncbi.nlm.nih.gov/pubmed/34753228 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2021.09.005 |
Ejemplares similares
-
血液肿瘤嵌合抗原受体自然杀伤细胞治疗研究进展
Publicado: (2022) -
嵌合抗原受体T细胞的结构演变及展望
Publicado: (2020) -
嵌合抗原受体T细胞治疗老年恶性血液病的安全性及疗效初步探讨
Publicado: (2018) -
嵌合抗原受体T细胞相关脑病综合征一例
Publicado: (2020) -
通用型嵌合抗原受体T细胞治疗的研究进展
Publicado: (2021)